Earnings season has started quite strong and the recent developments in Europe should keep bears in check.
Equity valuations, while still attractive, are no longer the bargain they were back in August and September.
Whether precious metals rise or fall, investors could perhaps profit from the gold/platinum ratio returning to something a little closer to normal.
The healthcare giant is one of our largest individual company positions, because it has the best combination of factors we can find for the future we envision.
While long-term I am bullish about the company's prospects, short-term I am less optimistic and shall be looking to exit my position.
My philosophy is not to follow Warren Buffett into BAC, but rather to invest with the principles that made value conscious investors like Buffett successful.
Can buying stocks that have performed well and selling stocks that have performed poorly help generate significant returns?
The stock has had a great run in 2011, but the price action and underlying supply/demand picture in GMCR was raising some concern.